Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rejuven8 is a brand name primarily associated with various dietary supplements and nutraceutical products, most notably a nitric oxide-boosting formula developed by Bionox. The Bionox Rejuven8 supplement is designed to support cardiovascular health and circulation by providing a blend of L-arginine and L-citrulline, which act as precursors for the endogenous production of nitric oxide. This signaling molecule facilitates vasodilation, thereby improving blood flow and supporting healthy blood pressure levels. Other formulations under the Rejuven8 name include skin-rejuvenation serums and general anti-aging supplements containing antioxidants, vitamins, and minerals. Because the name is used by multiple manufacturers for distinct formulations, its specific composition and intended use vary by product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rejuven8.